Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix protein, p17

Molecular Medicine

Volumn 3, Issue 2, 1997, Pages 96-110

  Levin, Reuven ^a,e   Mhashilkar, Abner M ^a   Dorfman, Tatyana ^a,b   Bukovsky, Anatoly ^a,b   Zani, Christy ^a,b   Bagley, Jessamyn ^a,b   Hinkula, Jorma ^c   Niedrig, Mattias ^d   Albert, Jan ^c   Wahren, Britta ^c   Göttlinger, Heinrich G ^a,b   Marasco, Wayne A ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d ROBERT KOCH INSTITUTE   (Germany)

^e ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; EPITOPE; IMMUNOGLOBULIN F(AB) FRAGMENT; MATRIX PROTEIN; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOPRECIPITATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE; VIRION; VIRUS DNA CELL DNA INTERACTION; VIRUS GENE; VIRUS PARTICLE; VIRUS REPLICATION;

EID: 8244221014     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401802     Document Type: Article

References (60)

1. Baltimore D. (1988) Intracellular immunization. Nature 335: 395-396.
2. Gilboa E, Smith C. (1994) Gene therapy for infectious diseases: The AIDS model. Trends in Genet. 10: 139-144.
3. Marasco WA, Haseltine WA, Chen SY. (1993) Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody. Proc. Natl. Acad. Sci. U.S.A. 90: 7889-7893.
4. Marasco WA. (1995) Intracellular antibodies (intrabodies) as research reagents and therapeutic molecules for gene therapy. Immunotechnology 1: 1-19.
5. Chen S-Y, Khouri Y, Bagley J, Marasco WA. (1994) Combined intra- and extracellular immunization against human immunodeficiency virus type 1 infection with a human anti-gp120 antibody. Proc. Natl. Acad. Sci. U.S.A. 91: 5932-5936.
6. Chen S-Y, J. Marasco WA. (1994) Intracellular antibodies as a new class of therapeutic molecules for gene therapy. Hum. Gene Ther. 5: 595-601.
7. Mhashilkar A, Bagley J, Chen S-Y, Szilvay AM, Helland DG. Marasco WA. (1995) Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies. EMBO J. 14: 1542-1551.
8. Duan L, Bagasra O, Laughlin MA, Oakes JW, Pomerantz RJ. (1994) Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody. Proc. Natl. Acad. Sci. U.S.A. 91: 5075-5079.
9. Maciejewski JP, Weichold FF, Young NS, et al. (1995) Intracellular expression of antibody fragments against HIV reverse transcriptase prevents HIV infection in vitro. Nature Mag. 1: 667-673.
10. Bukrinsky MI, Haggerty S, Dempsey MP, et al. (1993) A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365: 666-669.
11. von Schwedler U, Kornbluth RS, Trono D. (1994) The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 91: 6992-6996.
12. Bukrinsky MI, Sharova N, McDonald TL, Pushkarskaya T, Tarpley WG, Stevenson M. (1993) Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Natl. Acad. Sci. U.S.A. 90: 6125-6129.
13. Sharova N, Bukrinskaya A. (1991) p17 and p17-containing gag precursors of input human immunodeficiency virus are transported into the nuclei of infected cells. AIDS Res. Hum. Retroviruses 7: 303-306.
14. Emerman M, Bukrinsky M, Stevenson M. (1994) HIV-1 infection of non-dividing cells. Nature 369: 107-108.
15. Heinzinger NK, Bukrinsky MI, Haggerty SA, et al. (1994) The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. U.S.A. 91: 7311-7315.
16. Spearman P, Wang J-J, Vander Heyden N, Ratner L. (1994) Identification of human immunodeficiency virus type 1 gag protein dominates essential to membrane binding and particle assembly. J. Virol. 68: 3232-3242.
17. Zhou W, Parent LJ, Wills JW, Resh MD. (1994) Identification of a membrane-binding domain within the amino terminal region of human immunodeficiency virus type 1 gag protein which interacts with acidic phospholipids. J. Virol. 68: 2556-2569.
18. Bryant M, Ratner L. (1990) Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. U.S.A. 87: 523-527.
19. Göttlinger HG, Sodroski JG, Haseltine WA. (1989) Role of capsic precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 86: 5781-5785.
20. Pal R, Reitz MS Jr, Tschachler, Gallo RC, Sarngadharan MG, Di Marzo Veronese F. (1990) Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly. AIDS Res. Hum. Retroviruses 6: 721-730.
21. Dorfman T, Mammano F, Haseltine WA, Göttlinger HG. (1994) Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 68: 1689-1696.
22. Yu X, Yuan X, Matsuda Z, Lee T-H, Essex M. (1992) The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J. Virol. 66: 4966-4971.
23. Yu X, Yu Q-C, Lee T-H, Essex M. (1992) The C terminus of human immunodeficiency virus type 1 matrix protein is involved in early steps in virus life cycle. J. Virol. 66: 5667-5670.
24. Bukrinskaya AG, Ghorpade A, Heinzinger NK, Smithgall E, Lewis RE, Stevenson M. (1996) Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. Proc. Natl. Acad. Sci. U.S.A. 93: 367-371.
25. Gallay P, Swingler S, Aiken C, Trono D. (1995) HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell 80: 379-388.
26. Gallay P, Swingler S, Song J, Bushman F, Trono D. (1995) HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 83: 569-576.
27. Bagley J, Dillon PJ, Rosen C, Robinson J, Sodroski J, Marasco WA. (1994) Structural characterization of broadly neutralizing human monoclonal antibodies against the CD4 binding site of HIV-1 gp120. Mol. Immunol. 31: 1149-1160.
28. Marasco WA, Bagley J, Zani C, et al. (1992) Characterization of the CDNA of a broadly reactive neutralizing human anti-gp120 monoclonal antibody. J. Clin. Invest. 90: 1467-1478.
29. Niedrig M, Hinkula J, Weigelt W, et al. (1989) Epitope mapping of monoclonal antibodies against human immunodeficiency virus type 1 structural proteins by using peptides. J. Virol. 63: 3525-3528.
30. 2-macroglobulins and other related proteins. In: Sequences of Proteins of Immunological Interest. U.S. Department of Health and Human Services, NIH Publication No. 91-3242, Washington, DC.
31. Göttlinger HG, Dorfman T, Cohen EA, Haseltine WA. (1993) Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc. Natl. Acad. Sci. U.S.A. 90: 7381-7385.
32. Helseth E, Kowalski M, Gabuzda D, Olshevsky U, Haseltine W, Sodroski J. (1990) Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants. J. Virol. 64: 2416-2420.
33. Johnson VA, Byington RE. (1990) Quantitative Assays for Virus Infectivity. In: Aldovini A, Walker BD (eds), Techniques in HIV Research. Stockton Press, Stockholm, NY, pp. 71-96.
34. Li G, Simm M, Potash MJ, Volsky DJ. (1993) Human immunodeficiency virus type 1 DNA synthesis, integration, and efficient viral replication in growth-arrested T cells. J. Virol. 67: 3969-3977.
35. Innis MA, Gelfand DH, Sninsky JJ, White TJ. (eds.) (1990) PCR Protocols. In: A Guide to Methods and Applications. Academic Press, San Diego, CA.
36. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen ISY. (1990) HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure. Cell 61: 213-222.
37. Duke GM, Hoffman MA, Palmenberg AC. (1992) Sequence of structural elements that contribute to efficient encephalomyocarditis virus RNA translation. J. Virol. 66: 1602-1609.
38. Elroy-Stein O, Fuerst TR, Moss B. (1989) Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5′ sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system. Proc. Natl. Acad. Sci. U.S.A. 86: 6126-6130.
39. Louwagie J, McCutchan FE, Peeters M, et al. (1993) Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS 7: 769-780.
40. Ansari-Lari MA, Donehower LA, Gibbs RA. (1995) Analysis of human immunodeficiency virus type 1 integrase mutants. Virology 211: 332-335.
41. Engelman A, Englund G, Orenstein JM, Martin MA, Craigie R. (1995) Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J. Virol. 69: 2729-2736.
42. Lewis P, Hensel M, Emerman M. (1992) Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J. 11: 3053-3058.
43. Sakai H, Kawamura M, Sakuragi J-I, et al. (1993) Integration is essential for efficient gene expression of human immunodeficiency virus type 1. J. Virol. 67: 1169-1174.
44. Wiskerchen M, Muesing MA. (1995) Human immunodeficiency virus type 1 integrase: Effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells. J. Virol. 69: 376-386.
45. Stevenson M, Haggerty S, Lamonica CA, Meier CM, Welch S-K, Wasiak AJ. (1990) Integration is not necessary for expression of human immunodeficiency virus type 1 protein products. J. Virol. 64: 2421-2425.
46. Willey RD, Maldraelli F, Martin MA, Strebel K. (1992) Human immunodeficiency virus type 1 vpu protein regulates the formation of intracellular gp120-CD4 complexes. J. Virol. 66: 226-234.
47. Fenyö EM, Albert J, Åsjö B. (1989) Replication capacity, cytopathic effect and cell tropism of HIV. AIDS 3: S5-S12.
48. Blomberg J, Medstrand P. (1990) A sequence of the carboxyl terminus of the HIV-1 matrix protein is highly similar to sequences in membrane-associated proteins of other RNA viruses: Possible functional implications. New Biologist 2: 1044-1046.
49. Biocca S, Ruberti F, Tafani M, Pierandrei-Amaldi P, Cattaneo A. (1995) Redox state of single chain Fv fragment targeted to the endoplasmic reticulum, cytosol and mitochondria. Biotechnology 13: 1110-1115.
50. Duan L, Zhang H, Oakes JW, Bagasra O, Pomerantz RJ. (1994) Molecular and virological effects of intracellular anti-rev single-chain variable fragments on the expression of various human immunodeficiency virus-1 strains. Hum. Gene Ther. 5: 1315-1324.
51. Gelderblom HR, Hausmann EHS, Özel M, Pauli G, Koch MA. (1987) Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology 156: 171-176.
52. Bukrinsky MI, Sharova N, Dempsey MP, et al. (1992) Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. U.S.A. 89: 6580-6584.
53. Lewis PF, Emerman M. (1994) Passage through mitosis is required for oncoretroviruses but not for human immunodeficiency virus. J. Virol. 68: 510-516.
54. Roe TY, Reynolds TC, Yu G, Brown PO. (1993) Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12: 2089-2108.
55. Lodge R, Göttlinger H, Gabuzda D, Cohen EA, Lemay G. (1994) The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells. J. Virol. 68: 4857-4861.
56. Morikawa Y, Kishi T, Zhang WH, Nermut MV, Hockley DJ, Jones IM. (1995) A molecular determinant of human immunodeficiency virus particle assembly located in matrix antigen p17. J. Virol. 69: 4519-4523.
57. Myers G, Korber B, Wain-Hobson S, Jeang K-T, Henderson LE, Pavlakis GN. (1994) Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos National Laboratory, Los Alamos, New Mexico.
58. Freed EO, Orenstein JM, Buckler-White AJ, Martin MM. (1994) Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J. Virol. 68: 5311-5320.
59. Choo V. (1995) Combination superior to zidovudine in Delta trial. Lancet 346: 895.
60. Collier AC, Coombs RW, Schoenfeld DA, Bassett R, Baruch A, Corey L. (1995) Extended treatment with saquinavir (SAQ), zidovudine (ZDV), and zalcitabine (ddc) vs SAQ and ZDV vs ddc and VDZ. In: Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, September 17-20, 1995. American Society for Microbiology, Washington, D.C. 236 [Abstract].